Investors
Ceregene was launched in January 2001. Our investors include Alta Partners, MPM Capital, Investor Growth Capital and and BioSante Pharmaceuticals (Nasdaq: BPAX), as well as Hamilton BioVentures and California Technology Partners. We raised $10.5 million in our initial financing and $32 million in our Series B financing in 2004, led by Alta Partners and MPM Capital. In the first quarter of 2007, we raised an additional $28.1 million in our Series C financing, led by Investor Growth Capital.
